Company Biocept, Inc.

Equities

BIOCQ

US09072V6002

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 10:55:54 2024-03-25 am EDT 5-day change 1st Jan Change
0.0001 USD +9,900.00% Intraday chart for Biocept, Inc. 0.00% -99.76%

Business Summary

Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name CNSide. CNSide encompasses a suite of cellular and molecular technologies intended to aid medical professionals in CSF analysis and central nervous system (CNS) disease management in patients with solid tumors. It offers and conducts its commercialized diagnostic assays, which include cell capture and enumeration, immunocytochemistry, fluorescent in situ hybridization (FISH), and next generation sequencing (NGS). It has commercialized its CNSide assays for detecting and characterizing many different carcinomas and melanoma. These assays utilize its dual cellular and ctDNA technology platforms and provide biomarker analysis from a patient's CSF sample.

Number of employees: 50

Sales per Business

USD in Million2021Weight2022Weight Delta
Commercial
99.1 %
61 99.5 % 26 99.1 % -57.96%
Development Services
0.9 %
0 0.2 % 0 0.9 % +63.27%
Kits and Specimen Collection Tubes (SCT)
0.0 %
0 0.3 % 0 0.0 % -98.83%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
100.0 %
61 100.0 % 26 100.0 % -57.78%

Managers

Managers TitleAgeSince
Chief Tech/Sci/R&D Officer - 19-12-31
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 60 22-03-07
Compliance Officer 59 22-02-09
Comptroller/Controller/Auditor 31 22-04-30
Corporate Officer/Principal - 21-08-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,626,026 2,626,006 ( 100.00 %) 0 100.00 %
Stock B 0 2,090 0 0

Shareholders

NameEquities%Valuation
The Lind Partners LLC
0.1851 %
4,861 0.1851 % 0 $
Bruce Gerhardt
0.000571 %
15 0.000571 % 0 $
Ivor Royston
0.000076 %
2 0.000076 % 0 $
1 0.000038 % 0 $
0 0.000000 % - $
0 0.000000 % - $
0 0.000000 % - $
0 0.000000 % - $
Darrell Taylor
0.000000 %
0 0.000000 % - $
Robert Walsh
0.000000 %
0 0.000000 % - $

Company contact information

Biocept, Inc.

9955 Mesa Rim Road

92121, San Diego

+858 320 8200

http://www.biocept.com
address Biocept, Inc.(BIOCQ)